Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

This study has been completed.
Information provided by (Responsible Party):
ViiV Healthcare Identifier:
First received: February 27, 2014
Last updated: September 29, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2016
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 10, 2015